CAS: 360-66-7; Androisoxazole

该化合物是一种化学化合物,属于异氧新诺明类别,是五种含有氮和氧的杂交环状化合物,其特点是独特的双环结构,包括一个结合的异氧新诺明和一个腐蚀性松动,有助于其生物活动;Andoroisoxazole经常被研究其潜在的药理特性,特别是在...

结构式图片

物理性质

MSDS等安全信息

    上下游产品

    CAS号78964-17-7 17β-Hydroxy-2-(... | CAS号434-07-1 康复龙

    合成工艺路线路线简述

      📜羟甲烯龙置于羟胺乙酸盐体系中,用 乙醇 用作溶剂,化学反应 1.0H,反应生成雄异恶唑
      参考文献:De Ruggieri,P. Et Al.,Gazzetta Chimica Italiana,1962,Vol. 92,P. 768-798
      标题:De Ruggieri,P. Et Al.,Gazzetta Chimica Italiana,1962,Vol. 92,P. 768-798

      海关参考信息

      专利信息


      专利号:US-2025281509-A1
      优先权日:2021-04-26
      标 题 :Sequential hormone therapy to improve survival and enhance response to immune therapy in men with prostate cancer
      发明人：DENMEADE SAMUEL R; ISAACS JOHN T; ANTONARAKIS EMMANUEL S; KACHHAP SUSHANT; MARKOWSKI MARK CHRISTOPHER
      权利人:UNIV JOHNS HOPKINS
      摘要:Disclosed are methods for treating men with castrate resistant prostate cancer with a sufficient dose of testosterone to achieve supraphysiologic serum levels of testosterone in sequence with androgen ablative treatment or androgen synthesis inhibitors for one or more cycles until evidence of radiographic progression, at which point the subject will receive immune checkpoint blockade therapy.

      其他信息查阅

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      实用工具

      ⚠️全国化工行业净网倡议书
      📋制造商识别码
      📖 海关编码查询
      📝MSDS生成器

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Farmaco, Edizione Scientifica., 16(633), 1961
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知